Carnrite Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Siren Biotechnologysirenbiotechnology.comin𝕏Apr 2024
Siren Biotechnology develops next-generation AAV (adeno-associated virus) platforms for gene therapy applications, including gene repair, gene transfer, and gene editing.
BiotechDigital HealthMedical DevicesSan Francisco, US
Dr. Nicole Paulk(CEO, Founder, and President)Nicole Paulk(Executive Officer, Director)Lauren Kelly(Founder)inSharon Tetlow(Director)Brad Allen(Director)
Co-investorsArtis VenturesAvilaCivilization Ventures Management, LlcHAWKTAILNZVCPlum Alley Investments+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.